Qingdao Haier Biomedical Co., Ltd. Provides Earnings Guidance for the Year 2019
January 16, 2020
Share
Qingdao Haier Biomedical Co., Ltd. provided earnings guidance for the year 2019. According to preliminary statistics of its financial department, the company predicts that the net profit belonging to shareholders of the listed company in 2019 will be between RMB 170,936,600 and RMB 193,728,100 with an increase of between RMB 56,978,900 and RMB 79,770,400 and an increase of between 50% and 70% compared with the same period of the year before (based on the disclosed statistics according to relevant regulations). The net profit belonging to shareholders of the listed company after excluding extraordinary profit and loss will be between RMB 149,340,800 and RMB 171,465,300 with an increase of between RMB 94,029,400 and RMB 116,153,900 and an increase of between 170% and 210% compared with the same period of the year before (based on the disclosed statistics according to relevant regulations).
Qingdao Haier Biomedical Co Ltd is a China-based company mainly engaged in the research and development (R&D), production and sales of biomedical low-temperature storage products. The Company's main businesses include: providing biomedical low-temperature storage solutions covering the whole temperature range for scenarios such as sample safety, drug and reagent safety, vaccine safety and blood safety, as well as automatic, intelligent and comprehensive upgrading based on user needs, and providing integrated solutions for Internet of Thing (IoT) scenarios covering a variety of biosafety products. The Company's products are sold to domestic and overseas markets.
QINGDAO HAIER BIOMEDICAL CO.,LTD 
